Stock Scorecard

Stock Summary for Radiopharm Theranostics Ltd (RADX) - $4.49 as of 6/4/2026 6:57:52 AM EST

Total Score

16 out of 30

Safety Score

16 out of 100

Currently on the following lists
Small Cap Stock List
Tim's Recommendation
Possible Buy

Growth List Algorithm Criteria for RADX

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for RADX

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for RADX

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for RADX

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for RADX (16 out of 100)

Stock Price Rating (Max of 10) 3
Historical Stock Price Rating (Max of 10) 1
Stock Price Trend (Max of 10) 0
Book Value (Max of 10) 3
Book Value to Price (Max of 10) 1
Analyst Buy Ratings (Max of 5) 3
Analyst Strong Buy Ratings (Max of 5) 3
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 2
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Financial Details for RADX

Company Overview
Ticker RADX
Company Name Radiopharm Theranostics Ltd
Country USA
Description Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs. The company is headquartered in Carlton, Australia.
Sector Name HEALTHCARE
Industry Name BIOTECHNOLOGY
Most Recent Quarter 6/30/2025
Next Earnings Date N/A

Stock Price History
Last Day Price 4.49
Price 4 Years Ago 0.00
Last Day Price Updated 6/4/2026 6:57:52 AM EST
Last Day Volume 32,947
Average Daily Volume 37,394
52-Week High 10.63
52-Week Low 3.62
Last Price to 52 Week Low 24.03%

Valuation Measures
Trailing PE N/A
Industry PE 101.33
Sector PE 65.46
5-Year Average PE -2.41
Free Cash Flow Ratio 0.97
Industry Free Cash Flow Ratio 31.52
Sector Free Cash Flow Ratio 33.13
Current Ratio Most Recent Quarter 3.37
Total Cash Per Share 4.62
Book Value Per Share Most Recent Quarter 3.23
Price to Book Ratio 1.15
Industry Price to Book Ratio 5.56
Sector Price to Book Ratio 7.38
Price to Sales Ratio Twelve Trailing Months 2.20
Industry Price to Sales Ratio Twelve Trailing Months 8.90
Sector Price to Sales Ratio Twelve Trailing Months 4.69
Analyst Buy Ratings 3
Analyst Strong Buy Ratings 1

Share Statistics
Total Shares Outstanding 7,883,200
Market Capitalization 35,395,568
Institutional Ownership 2.54%

Dividends
Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement
Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth 20.04%
Reported EPS 12 Trailing Months -3.79
Reported EPS Past Year -2.10
Reported EPS Prior Year -1.98
Net Income Twelve Trailing Months 0
Net Income Past Year -38,342,457
Net Income Prior Year -47,949,119
Quarterly Revenue Growth YOY 154.50%
5-Year Revenue Growth 643.76%
Operating Margin Twelve Trailing Months -423.70%

Balance Sheet
Total Cash Most Recent Quarter 36,436,938
Total Cash Past Year 29,116,835
Total Cash Prior Year 18,575,040
Net Cash Position Most Recent Quarter 36,436,938
Net Cash Position Past Year 29,116,835
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 44,792,004
Total Stockholder Equity Prior Year 28,122,562
Total Stockholder Equity Most Recent Quarter 53,202,003

Free Cash Flow
Free Cash Flow Twelve Trailing Months -33,458,466
Free Cash Flow Per Share Twelve Trailing Months -4.24
Free Cash Flow Past Year -36,645,477
Free Cash Flow Prior Year -22,975,935

Options
Put/Call Ratio 0.00
Has Options False
Liquidity Rating None

Technical Analysis
Yahoo Finance Chart Yahoo Finance Chart
MACD 0.00
MACD Signal 0.00
20-Day Bollinger Lower Band 0.00
20-Day Bollinger Middle Band 0.00
20-Day Bollinger Upper Band 0.00
Beta 0.78
RSI 0.00
50-Day SMA 0.00
150-Day SMA 0.00
200-Day SMA 0.00

System
Modified 6/4/2026 6:57:53 AM EST